FON-2021-1486 Infographic.jpg (4.8 MB)
Infographic – STARBOARD: encorafenib + binimetinib + pembrolizumab for 1st-line metastatic/unresectable BRAF V600MT melanoma
figure
posted on 2022-03-11, 08:38 authored by Figshare Future Science GroupFigshare Future Science Group, Chizoba Nwankwo, Ruchit Shah, Anuj Shah, Shelby Corman, Nehemiah Kebede
Infographic: Design of the STARBOARD trial
|